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Summary 
CD4 is the coreceptor molecule expressed on the surface of T cells specific for or restricted by 
class II molecules of the major histocompatibility complex (MHC). Its expression on T  cells 
is required for an optimal response to antigen (Ag). Three mechanisms have been invoked for 
the involvement of CD4 in T cell activation. First, it was shown that CD4 binds to MHC class 
II molecules on antigen presenting cells (APCs) thereby favoring an adhesion between effector 
cells and APCs. Association of CD4 to the T cell receptor and to the tyrosine kinase p56 ~k have 
also been shown to be critically involved in the positive function of CD4. Here, we demonstrate 
that the interaction of CD4 with p56  ~  is not required to enhance the response of two CD4- 
dependent, Ag-specific T cell hybridomas. Mutant forms of CD4 (TCD4), which lose assoda- 
tion to p56 kk, were expressed in these T cells and were shown to enhance the Ag-specific re- 
sponse as effidently as the wild-type CD4.  Moreover both CD4-dependent and independent 
T cell responses were inhibited by CD4-specific mAbs even when CD4 was not associated with 
p56  ~k. These results indicate that mechanisms distinct from sequestration of p56  ~  and/or nega- 
tive signaling operate in these inhibitions. Results demonstrating enhancement  of TCR-mediated 
signaling by the coaggregation of TCD4 mutant to the TCK further confirm that the association 
of p56  ~k to CD4 is not absolutely required for the regulatory functions of CD4.  Our results 
suggest that the mechanisms implicated in the enhancement of T cell stimulation via CD4 de- 
pend solely on the extracellular and transmembrane domains of CD4. 
T 
he CD4 molecule is a cell surface glycoprotein of 55,000 
mol wt, expressed on the T cell subset that recognizes 
its Ag in the context of the MHC dass II molecules (reviewed 
in 1). It belongs to the Ig superfamily and possesses four Ig- 
like domains, a transmembrane region, and a cytoplasmic tail 
(2) that allows assodation with the tyrosine kinase p56  uk (3). 
This association involves cysteines 420 and 422 of CD4 and 
cysteines 20 and 23 of p56 kk that may contribute to the for- 
mation of a metal ion coordination complex (4,  5). 
The requirement for CD4 in thymocyte maturation and 
in Ag-specific responses of mature T cells is well established 
(1). CD4 has been shown to have an adhesion function medi- 
ated through its interaction with MHC class II molecules 
(6), thereby increasing the stability of the TCR/Ag/MHC 
complex (7).  The amino acids involved in this interaction 
have been mapped to the first and second domain of the CD4 
molecule (8, 9). Although mouse CD4 (L3T4) and human 
CD4 only show 55%  homology in their extracellular do- 
main, human CD4 has been demonstrated to fully replace 
its murine counterpart in Ag-specific stimulation (10) and 
in thymocyte differentiation  (11). Conversely, residues on 
MHC class II molecules that interact with CD4 are highly 
conserved throughout evolution and are located in the non- 
polymorphic region of the 82 domain (12). 
CD4 can also affect TCIL-mediated stimuli;  aggregation 
of CD4 with the TCK by CD4 and TCR-specific mAbs leads 
to the enhancement of TCR-mediated stimulation whereas 
cross-linking of CD4 molecules with spedfic mAbs before 
activation through the TCK results in the loss of T cell re- 
sponses (13, 14). The association of CD4 with the tyrosine 
kinase  p56 ~k  was  demonstrated,  providing  a  mechanism 
whereby CD4 could now play in addition to its adhesion 
function a receptor role by transducing a signal through this 
kinase. Indeed the tyrosine kinase activity of p56 k~ is en- 
hanced upon cross-linking of CD4 with specific mAbs; fur- 
thermore, one of the phosphorylated substrates is the ~" subunit 
of the TCK complex (15). On the other hand, sequestration 
of p56  kk from the TCR complex when CD4 is not recruited 
to the vicinity of the TCK has been shown to inhibit anti- 
TCK-mediated T  cell activation  (16). 
1973  J. Exp.  Med. ￿9  The Rockefeller  University Press ￿9 0022-1007/94/06/1973/11  $2.00 
Volume  179  June 1994  1973-1983 Several reports have indicated that CD4 can interact with 
other cell surface molecules on T  cells, i.e.,  the CD3/TCR 
complex (17) CD45 (18);  and suggested that these interac- 
tions are critical for T  cell activation. The role of CD4 in 
T  cell activation can thus be mediated by binding to MHC 
class II molecules, colocalization of CD4 with TCR or other 
cell surface molecules, and activation of p56  kk. These events 
would lead to optimal T  cell stimulation. 
In this report, we have used two different T  cell hybrid- 
omas in order to determine the importance of CD4 interac- 
tion with its multiple ligands; we demonstrate, using two 
Ag-specific systems, that the enhancement by CD4 of an Ag- 
specific response or other TCR-mediated stimuli occurs even 
if CD4 is not associated with p56  k~. This function is totally 
abrogated by CD4-specific mAbs even when a mutated form 
of CD4,  not associated  with p56  kk,  is used.  These results 
reduce  the  importance  of the  CD4:p56  ~k  association  in 
CD4-mediated enhancement of T cell activation. Moreover, 
they emphasize the role of the interactions of the extracel- 
lular domain of CD4 with its different ligands. 
Materials  and Methods 
Cells.  The male (H-Y) Ag-specific  T cell hybridoma KR3 and 
the beef  and pork insulin-specific  T cell hybridoma BI-83/141 have 
been already described (19, 20). They were maintained in RPMI 
1640 medium,  supplemented with  10%  heat  inactivated FCS, 
5 x 10 -s M ~-mercaptoethanol,  1 mM sodium pyruvate, 10 mM 
Hepes, and 2  x  10 -s M gentarnicine (all purchased from GIBCO 
BRL, Burlington,  Ontario,  Canada). 
The FT5 7H2 L ceils transfected with the murine MHC class 
II I-A ~vbBk  molecules (gift from N. Braunstein, Columbia Univer- 
sity, New York) were used as APCs for the beef insulin-specific 
(BI)  1 hybridoma  and  were  maintained  in  DMEM  5%  FCS 
(GIBCO BRL). APCs for the K~  hybridoma are splenocytes  from 
male or female C57B1/6 or DBA/2 mice (Charles River Canada, 
St-Constant,  Qurbec,  Canada). The  IL-2-dependent  cell line 
CTLL.2 was maintained in complete RPMI with  10 IU/ml of 
recombinant human IL-2 (Cetus Corp., Emoryville, CA). DAMP 
is a dog amphotropic packaging cell line maintained in culture in 
DMEM supplemented with 5% FCS. 
Reagents.  Beef and pork insulin were purchased from Sigma 
Chemical Co. (Canada, Mississauga, Ontario, Canada). G418 from 
GIBCO BRL, mitomycin C from Sigma Chemical Co. (St. Louis, 
MO),  [3H]thymidine methyl  (81.3 Ci/mmol)  from  Du  Pont 
Canada (Mississauga, Ontario,  Canada). 
Antibodies.  The mAb F23.1, a specific anti-mouse TCR VB8 
was provided by P. Marrack (National Jewish Center, Denver, CO). 
mAbs L68 and L93, two human CD4-specific  mAbs, were provided 
by D. Buck (Becton Dickinson, Monoclonal Antibody Center, San 
Jose, CA), OKT4 by American Type  Culture Collection (ATCC; 
Rockville, MD), Q425 by Q. Sattentau (Institut  d'Immunologie 
Marseille-Luminy,  Marseille, France). GK1.5 is an anti-mouse L3T4 
mAb (ATCC), IM7 is an anti-mouse  PGP-1 mAb (ATCC). 
Plasmids.  The CD4 constructs were subdoned in the pMNC 
recombinant retroviral vector. It confers resistance to the selective 
agent G418 and allows stable expression of CD4 molecules in in- 
fected cells (21). The wild-type  (wt) human CD4 is a gift from 
1Abbreviations used in thispaper: BI, bed insulin-specific  hybridoma; GAM, 
goat anti-mouse Ig; r, recombinant;  SAG, super antigen; wt, wild-type. 
A. Peterson and B. Seed (Massachusetts General Hospital, Boston, 
MA), the truncated CD4 molecule from E. Long (Laboratory of 
Immunogenetics, National Institute of Allergy and InL-ctious  Dis- 
eases, National Institutes of Health, Bethesda, MD), C420 2A CD4 
was obtained from 5. Gratton (Institut de Recherches Cliniques 
de Montrral, Montreal,  Canada) (22). 
DNA-mediated  Gene Transfer.  DAMP  cells expressing  the 
different forms of human and murine CD4 were obtained by the 
calcium phosphate coprecipitation technique (23). T cell hybrid- 
omas expressing CD4 were obtained by coculturing the CD4- T 
cell hybridoma (106 cells) and mitomycin C (50/zg/ml, 45 min, 
37~  treated DAMP cells (70% confluent flask) for 24 h with 
polybrene at 4/~g/ml. T cells were then washed and incubated 
for another 24 h before selecting transfectants by adding G418 (1 
mg/ml for BI and 2.5 mg/ml for KR3). Stable popuhtions were 
obtained by aseptic cell sorting on a FACstar  |  Plus (Becton Dick- 
inson  Immunocytometry Systems, San Jose, CA) or single cell 
cloning (for KR3 cells) and further analyzed for CD4 expression. 
Flow Cytometry Analysis.  Expression of the CD4 and TCR 
molecules were monitored  by staining  the cells with either an 
anti-human CD4-mAb  (I.93) or with an antimurine TCR VB8 
mAb (F23.1). 0.5-1  x  106 cells were incubated on ice for 30 rain 
with indicated mAbs, washed in PBS, and subsequently incubated 
with goat anti-mouse Ig (GAM) FITC (Becton Dickinson, Mis- 
sissauga, Ontario,  Canada) for 30 min on ice and washed. Cells 
were then analyzed for fluorescence  with a FACScan  |  flow cytom- 
eter (Becton Dickinson,  Immunocytometry Systems). For each 
histogram, live  cells gated by Propidium iodide exclusion were ana- 
lyzed on a log scale. As negative control, cells were stained with 
the secondary FITC-labeled antibody alone. Results are expressed 
in arbitrary units  of fluorescence. 
Ag Stimulation  of the  T  Cell Hybridoma 
131Hybridoma.  5  ￿  104 T cells were stimulated by incubation 
with 104 APCs and various concentrations of either beef or pork 
insulin for 24 h, at 37~  Supernatants from the cocuhures were 
assayed for II.-2 production  as described below. 
KR3 Hybridoma.  5  x  104 T cells were incubated for 24 h at 
37~  with various concentrations (6  x  106 to 104) of splenocytes 
from either C57B1/6 male mice expressing the H-Y Ag in the con- 
text of I-A  b or splenocytes from female as a negative control or 
female DBA/2 mice expressing Mls-P. Supernatants were assayed 
for IL-2 production. 
11_,2 Assay.  100 #1 of supernatants obtained from the T cell 
stimulation assays (or serial  dilutions 1:2 of supematant) were added 
to 5  x  103 CTLL.2 and incubated for 48 h at 37~  CTLL.2 
proliferation was measured by adding 0.25 #Ci/well of [3H]thymi- 
dine for 16 h. Wells were harvested and thymidine incorporation 
was counted with a B-plate counter (LKB Pharmacia Canada, Baie 
d'Urfr, Quebec, Canada). cpm were converted to IL-2 units using 
a standard curve of rlL-2. 
Stimulation with Coated  Antibodies.  Plates  were coated overnight 
with serial dilutions of anti-TCR mAb in PBS at 4~  Plates were 
then washed twice with PBS and 5  x  104 T cells were added per 
well and incubated for 16 h at 37~  IL-2 production  was then 
measured. When GAM (The  Jackson Laboratory, Bar Harbor, ME) 
was used to cross-link TCR and CD4 mAbs, 10 #g/ml of GAM 
diluted in PBS were coated on plates, incubated overnight at 4~ 
and wells were washed twice with PBS. 5  x  104 cells were then 
incubated on ice for 60 min with TCR and CD4 mAbs, washed 
twice with PBS, and resuspended in medium.  Cells (5  x  104) 
were added to the GAM-coated wells and incubated for 16 h at 
37~  IL-2 production  was then measured. 
1974  Positive  or Negative Role of CD4 Does Not Require Its Association to/ck Protein Analysis.  5  x  10  s T cell hybridoma were lysed in I00 
#1 loading buffer (2% SDS, 40 mM Tris HC1, 10% glycerol, 5% 
/3-mercaptoethanol, 0.001% bromophenol blue) and bored for 10 
rain. Supernatants were run on a gradient (5-10%) SDS polyacryl- 
amide get. After transfer onto nitrocellulose (S & S NC  TM, pore 
size 0.2  #m;  Mandel Scientific Co., Guelph,  Ontario,  Canada) 
binding  of the antiphosphotyrosine  mAb was performed for 2 h 
in TBST (20 mM Tris, pH 7.5, 150 mM NaC1, 0.1% Tween 20) 
with  2%  gelatin  and was revealed with  12SI-GAM (Amersham 
Corp., Oakville, Ontario,  Canada) on XAR film (Eastman Kodak 
Co.,  Rochester,  NY). 
Results 
Cytofluorometric Analysis of KR3 and BI Hybridomas Trans- 
fected with the wt and Mutated Human CD4 Molecules.  The 
human CD4 can fully replace L3T4 in the BI hybridoma and 
restore its response to low concentrations  of Ag (reference 
10 and data not shown), cDNAs encoding the human CD4 
molecule and two different mutants, TCD4 and C420, were 
stably introduced by infection into two L3T4 negative hy- 
bridoma variants 83/141 (BI) and KR3-  (specific for H-Y). 
The TCD4 mutant lacks the COOH-termina131 amino acids 
of the cytoplasmic tail while the C420 mutant has been ob- 
tained by substituting for alanines,  the two cysteines at posi- 
tions 420 and 422.  Cell surface expression of the different 
molecules  was  verified  by  FACScan  ~  analysis  using  an 
anti-human  CD4 (L93) mAb and an antimurine TCR V(38 
(F23.1) mAb (Fig.  1) or an antimurine CD4 (GKLS). Popu- 
lations expressing similar levds of the CD4 and TCR mole- 
cules were retained for functional and biochemical analysis. 
Analysis of the Intrinsic Capacity of Each Population to Pro- 
duce IL-2.  Aggregation of the TCR by the TCR-specific 
F23.1  mAb  adsorbed  on  plates  provides  an  independent 
stimulus to control the capacity of each line to secrete IL-2. 
Cells expressing wt CD4 (BICD4.3, KR3CD4.H8), TCD4, 
and C420 (in KR3 and BI) were as effzcient as wt CD4 ex- 
pressing populations  to respond to F23.1 mAb (Fig.  2, A 
and B, for BI and KR3, respectively) indicating  that  these 
populations had the same intrinsic capacity to produce IL-2 
upon aggregation  of their  TCRs. 
The Mls-l' superantigen (SAG) can strongly stimulate the 
KR3 hybridoma (19). To further confirm that these popula- 
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Figure 2.  T cell hybridomas transfected  with wt and mutant CD4 mol- 
ecules show a similar capacity to produce Ib2 upon a non-CD4-depen- 
dent  stimulus.  (A)  Each  BI  transfectant  (5  x  104  cells/well)  was 
stimulated with decreasing concentrations of F23.1 coated on plates and 
incubated at 37~  for 24 h. Supernatants were assayed for Ib2 production 
by measuring [3H]tbymidine incorporation of the Ib2-dependent CTLL.2 
line; IL-2 units are obtained using a standard curve generated with rIL-2. 
(B) KR3 transfectants (5  x  104 cells/well) were stimulated as in A and 
IL-2 production was measured using the Ib2--dependent  CTLL.2 line. 
(C) KR3 hybridomas  were  stimulated  with decreasing concentrations 
of Mls-l~-expressing splenocytes for 24 h and IL-2 production was then 
quantified as described above. 
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Figure  1.  Fluorescence  analysis  of the different popu- 
lations for the expression of TCR and CD4 molecules. 
Cells were  stained with the F23.1 (10 #g/ml) mAb 
specific for the routine TCR Vfl8 chain (-) and with 
the anti-human CD4 L93 (5 t~g/ml) (---), As a nega- 
tive control, cells were only stained with GAM-FITC 
and are represented in all panels by a histogram in bold; 
staining with the GK1.5-FITC mAb (anti-L3T4) is over- 
lapping with the negative control. Mean fluorescence 
is indicated on the top of each curve. Fluorescence is 
plotted on a four decade  log scale (x-axis) against number 
of  cells ~-axis). For each Ag-specific  system, transfected 
populations were chosen to express comparable levels 
of cell surface expression of CD4 and TCR molecules. 
1975  Zerbib et al. tions are comparable in terms of IL-2 production, KK3-, 
KCD4.HS,  KTCD4,  KC420  were stimulated  by DBA/2 
splenocytes. This response was CD4-independent since the 
KR3-  population showed the same capacity to respond to 
Mls-l' as wt CD4, TCD4, or C420 CD4 transfected cells. 
As shown in Fig. 2 C, all the clones tested produced equiva- 
lent amounts of IL-2, even in presence of the lowest concen- 
tration of Mls-l' expressing cells (1.25  x  104 Mls-lLex- 
pressing splenocytes). These results provide another evidence 
that these different populations  have the same intrinsic ca- 
pacity to produce IL-2 upon cross-linking of their TCR and 
can be further compared for their capacity to respond to a 
CD4-dependent antigenic stimulation. 
Lack of Association of CD4 with p56  kk Does Not Alter the 
Capacity of CD4 to Enhance Ag-specific Stimulation.  The re- 
quirement for the CD4:p56 ~  association in Ag specific re- 
sponses was verified in each one of these systems. BI cells 
respond to beef or pork insulin when presented by the mu- 
rine MHC class II molecule I-A ab/~  k. The BI L3T4 nega- 
tive variant (83/141) loses partially (with beef  insulin) or com- 
pletely (with pork insulin) its capacity to respond to its Ag 
when compared to the L3T4 + parental  cell line  (24). BI 
populations  expressing wt CD4 or TCD4 were stimulated 
by increasing concentrations  of beef or pork insulin in the 
presence of DAP-3  cells expressing  the I-A ~bflk murine 
MHC class II molecules. Both cell types were capable of 
producing high levels of IL-2 at 40 #g/m1 of beef insulin 
whereas the CD4 negative cell line (83/141) never produced 
comparable levels of IL-2 even at the higher concentrations 
of  beef insulin (Fig. 3 A). Interestingly, TCD4 was perfectly 
capable of restoring a pork insulin specific  response with the 
same efficacy as wt CD4. The half maximal IL-2 response 
for the BICD4.3 and BITCD4.20 populations (Fig. 3 B) oc- 
curred at the same pork insulin concentration (160 #g/ml). 
To further confirm this result we derived from independent 
infections several TCD4 + populations  expressing levels of 
TCD4 and TCK comparable to wt CD4 + calls. These cells 
produced significant amount of IL-2 when stimulated with 
160 #g/ml pork insulin and appropriate APCs, as compared 
with cells transfected with wt human or murine (L3T4) CD4 
(Fig. 3 C). These results demonstrate the lack of require- 
ment for the CD4:p56 ~k association in a CD4 dependent re- 
sponse; they emphasize the role of the extracellular domain 
of the CD4 molecule. 
To confirm this  statement,  we studied the effect of this 
mutation on the response to Ag of a second CD4-dependent 
T  cell hybridoma. The routine T  cell hybridoma KK3 is 
specific for the H-Y Ag when presented by the murine MHC 
class II I-A  s. The KR3 L3T4 negative variant (KR3-) loses 
the capacity to respond to cells expressing its specific antigen 
H-Y,  whereas  it  retained  the ability  to be stimulated  by 
Mls-P (19). KR3 wt CD4, TCD4, and C420 populations 
were stimulated with decreasing concentrations of male BL/6 
splenocytes (6-0.75  x  10  s cells) or 6  x  10  s female BL/6 
splenocytes (H-Y-). The wt human CD4 molecule was per- 
fectly capable of restoring the H-Y-specific response (Fig. 4 
A). Moreover the TCD4 molecule enhanced the reactivity 
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Figure 3.  Pork insulin-specific stimulation of the T cell hybridomas 
is dependent upon CD4 expression but association of CD4 with p56  kk 
is not requited.  (A and B) BI hybridomas were stimulated with antigen 
as described in Materials and Methods. Increasing concentrations of beef 
or pork insulin were incubated with APCs (104 cells) and T cells (5  x 
104) for 24 h at 37~  and supematants from the cocultures were assayed 
for I1.-2  by measuring [~H]tbymidine incorporation of the II.,2-dependent 
CTLL.2 line. (C) Comparison of II.-2 release between TCD4- or L3T4- 
expressing populations  stimulated  with  160 #g/nil pork insulin. The 
83/141 T cell hybridoma was infected with retroviruses containing the 
TCD4 or full-length  L3T4 cDNA as described in Materials and Methods. 
G418-resistant cells were selected. Each T cell hybridoma expressing wt 
CD4, TCD4, or L3T4 was analyzed by flow cytometry for its expression 
of TCK and CD4. Mean values of fluorescence for CD4 (top) and TCK 
(bottom) molecules are indicated on top of each histogram.  Cell surface 
expression of CD4 and TCR was obtained by flow cytometry as described 
in Fig. 1. Cocultures of APCs with the different T cell hybridomas were 
carried out as described in A. 1I.-2  units were obtained using the IL-2-de- 
pendent CTLL.2 assay. 
to H-Y as efficiently as wt CD4 (Fig. 4 A). Similar results 
were obtained with the C420 mutant with a dose response 
curve to H-Y + cells overhpping with the one obtained with 
wt CD4. Several  clones of TCD4 and C420 cells expressing 
comparable levels of CD4 and TCK were screened for their 
response to H-Y (Fig. 4 B); they all demonstrated the same 
capacity to respond to H-Y + APCs as cells expressing wt 
CD4. 
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Figure 4.  H-Y-specific  stimulation of the KR3 hybridoma is depen- 
dent upon CD4 expression  but does not require CD4:p56~ association. 
(A) KR3 hybridomas wgre stimulated with  several concentrations of 
male (H-Y  +) I-A  b B1/6 splenocytes  or 6  x  105 female B1/6 splenocytes 
for 24 h at 37~  Supernatants were assayed for IL-2 production by meas- 
uring [3H]thymidine incorporation in the Ib2-dependent  CTLL.2 line. 
(B) Screening of TCD4 and C420 expressing populations after stimula- 
tion with 5 x  106 male splenocytes. The KR3- bybridoma was infected 
with retroviruses  containing TCD4 or C420 mutants cDNAs as described 
in Materials and Methods. G418-resistant populations were selected  and 
each one of these hybrids were analyzed by flow cytometry for their ex- 
pression of CD4 and TCR. Mean fluorescences  for each T cell hybridoma 
used in these experiments are indicated on top of each histogram: CD4 
(top) and TCR (bottom). CeU surface expression of CD4 and TCR was 
obtained as described  in Fig. 1. Cocultures of different T cell hybridomas 
with splenocytes  were carried out as in (,4). ID2 units were obtained  using 
the IL-2-dependent CTLL.2 assay, 
Taken together,  these experiments confirm in two inde- 
pendent antigenic systems that mutants of CD4 that are not 
associated with p56  ~k have the same capacity as wt CD4 to 
rescue a CD4-dependent response. These results suggest that 
the enhancement ofT cell stimulation resulting from the ex- 
pression of CD4 in those cells, is only due to the involve- 
ment  of the extracellular/transmembrane  region of CD4. 
Inkt'~tion of  a CD4-dependent Ag Stimulation by Human CD4- 
specific mAbs.  Several reports have shown that CD4-depen- 
dent responses are inhibited by CD4-specific mAbs (25, 26). 
To assess  the specific involvement of CD4-associated  p56 ~k 
in this  inhibition,  cells were incubated with  a  CD4 mAb 
(L68) or L3T4 mAb (GK1.5) or an Ab recognizing an irrele- 
vant cell surface protein (PGP-1) before triggering with APCs 
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Figure 5.  Specific  inhibition of the pork insulin stimulation with anti- 
CD4 antibodies. T cell hybridomas (5 x  104) were incubated for 30 min 
on ice with decreasing concentrations of either the human CD4 (L68) 
mAb (5 - 0.005/~g/ml) or the murine CD4 (GK1.5)  mAb (2-0.002/~g/ml) 
or with the anti-PGP-1 mAb (5 #g/ml), Cells were then incubated with 
160/~g/ml of pork insulin in the presence of APCs (104 ceUs) for 24 h 
and supernatants were assayed for Ib2 production as already described: 
(,4) BICD4.3; (B) BITCD4,20; (C) BIL3T4. 
and specific Ag. Fig.  5 A  shows that L68 inhibited the re- 
sponse to pork insulin of cells expressing wt CD4 in a dose- 
dependent fashion. Interestingly, a similar pattern of inhibi- 
tion, with an identical dose response, was obtained for cells 
expressing TCD4 (Fig. 5 B) indicating that the CD4:p56 ~k 
association is not required for these inhibitions. Stimulation 
of control cells expressing L3T4 was not inhibited by L68 
but was abrogated by mAbs  specific for L3T4 (Fig.  5  C). 
Similar observations were made using KR3 cells expressing 
wt or mutant CD4 molecules. The CD4-specific mAb L68 
inhibited the H-Y-specific response of hybridomas expressing 
wt CD4 (Fig. 6 A), TCD4 (Fig. 6 B) and C420 CD4 (Fig. 
6 C). Control cells expressing L3T4 were inhibited with L3T4 
mAb but not with a human CD4-specific mAb (Fig. 6 D). 
Inhibition of T  cell response was never observed with the 
irrelevant anti-PGP-1  mAb. 
Our results demonstrate that the CD4 molecule enhances 
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Figure 6.  Specific  inhibition of the H-Y stimulation with an anti-CD4 
mAb. KR3 hybridoraas were incubated with the different mAbs, as in 
Fig. 5, before  incubation with 3 x  10  s H-Y + splenocytes  for 24 h; su- 
pematants were assayed  for Ib2 production as previously  described. (A) 
KCD4 H8, (B) KTCD4 G5, (C) KC420 G5, (D) KL3T4. 
Ag stimulation without being associated with the tyrosine 
kinase  p56  ~t.  This  enhancement  is  entirely  blocked  by 
human CD4-specific mAbs, even when mutant forms of CD4 
that  do not  interact  with  p56  kk are expressed,  confirming 
that the interaction of CD4 with its external ligands is crit- 
ical for CD4 to exert its functions. 
Inhi~tion of  a CD4-independent  Ag Response with Human CD4- 
specific mAbs.  In a CD4-dependent Ag-specific system, ac- 
tivation absolutely requires the extracellular domain of CD4 
interacting  with MHC class II, thus making it difficult to 
assess whether the CD4:p56 kk association is critical per se 
for the inhibition with CD4-specific mAbs. We thus studied 
the effect of CD4-specific mAbs on a response to Ag that 
is independent of the expression of CD4. As shown in Fig. 
2  C,  KR3  CD4 +  and  L3T4-  populations  responded  as 
efficiently to Mls-l' SAG. KR3-, KCD4, KC420, KTCD4, 
and KI.3T4 populations were incubated with decreasing con- 
centrations of CD4-specific mAbs before stimulation by Mls- 
1'-expressing splenocytes. Three different mAbs were used: 
L68, which maps to the V1 domain of the CD4 molecule; 
GK1.5 mAb, which is specific for L3T4; and IM7 mAb, which 
is specific  to PGP-1. 
As illustrated  in  Fig.  7,  CD4-specific mAbs  were very 
efficient  in  inhibiting  the Mls-P  response  although  CD4 
expression is not required for an optimal T  cell activation. 
Quantitative  differences were however observed in  the de- 
gree of inhibition with the various forms of CD4. Whereas 
wt CD4-expressing cells were reproducibly totally inhibited 
with  a saturating  concentration  of the CD4-specific mAb 
L68 (5 #g/ml), inhibition of the TCD4 (Fig. 7 C) and C420 
populations (Fig.  7 D) varied between 50 and 100% at the 
same concentrations  of L68 (Fig.  7  and data  not  shown). 
This inhibition was not due to cross-linking of CD4-specific 
mAbs by Fc receptors expressed on splenocytes,  since  the 
same pattern of inhibition was obtained after a stimulation 
with Fc receptor negative Mls-la/DRl-expressing DAP cells 
(data not shown). Altogether these results indicate that both 
CD4-dependent and CD4-independent responses are inhibited 
by CD4-specifc mAbs by a mechanism in which the CD4: 
p56 ~k association is not  involved. 
Enhancement of IL-2 Production by Cross-linking CD4  to 
the TCR Can Be Observed in Absence of  p56 ~k Associated with 
CD4.  Experiments were then set up to determine the role 
of the CD4:p56 kk association in  the enhancement  of anti- 
TCK specific responses by co-cross-linking the TCR with 
CD4 using specific mAbs. Such a system enables us to dis- 
sociate the adhesion from the signaling  function  of CD4. 
Cells were first incubated with a suboptimal concentration 
of anti-TCK together with or without a CD4- or a PGP- 
1-specific mAb. As shown in Fig. 8, a 10-fold enhancement 
of IL-2 production  (varying from 3- to  14-fold depending 
on  the experiment)  was noted in  the BI system when wt 
CD4 molecules were cross-linked to the TCR, as compared 
with aggregation of the TCK alone. A similar enhancement, 
although weaker (ranging from three- to sixfold depending 
on experiments), was obtained when the TCD4 mutant mol- 
ecule was co-cross-linked to the TCR. No enhancement was 
obtained by co-cross-linking  PGP-1  to  the TCR.  Similar 
results were obtained with the KK3 hybridoma expressing 
the wt or TCD4 or C420 mutant molecules (data not shown). 
Our data demonstrate  that  an additional  mechanism inde- 
pendent of CD4:p56 ~  association is involved in the above- 
described enhancement of TCg-mediated stimulation and re- 
quires  the extracellular  domain  of CD4. 
Enhancement of lL-2 Production Occurs Independently of the 
CD4:p56~-mediated Increase in Tyrosine  Phosphorylation.  We 
then verifed if the IL-2 enhancement  observed after cross- 
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Figure 7.  InhibitionofaCD4- 
independent stimulation with anti 
-CD4 mAbs.  KR3  hyhridomas 
(5  x  104 cells)  were  incubated 
for 60 min at 4~  with the var- 
ious mAbs, as in Figs. 5 and 6, 
before incubation  with 10  s Mls- 
1'  --expressing  splenocytes  for 
24 h at 37~  ID2 production was 
then  measur~  (A)  KR3-,  (B) 
KCD4 HS, (C) KTCD4.G5, (D) 
KC420 G5, (E) KL3T4. 
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Figure  8.  Cross-linking CD4 to the TCR complex enhances a subop- 
timal anti-TCR Ab stimulation. 83/141, BICD4.3, BITCD4.20 cells (5 
x  104) were incubated with a suboptimal dose of anti-TCR alone (F23.1, 
0.75 pg/ml) or together with varying concentrations of L68 or an anti- 
PGPl mAb (5 pg/ml) for 1 h on ice. Cells were washed twice, resuspended 
in medium, and incubated for 24 h in wells precoated with GAM (10/~g/ml). 
Supernatants were assayed for I1--2 production as already described. (The 
three populations express high level of PGP-1 and the GAM Ab binds to 
the anti-PGlXl very ef~dently as illustrated  by FACScan  |  analysis  by staining 
the cells with the anti-PGP-1  +  GAM-FITC.  Cells are 100% positive 
with a mean value of: 204 (83/143), 361 (TCD4.20), 477 (L3T4)  vs. a 
mean of 8  for GAM-FITC  alone). 
linking of the different CD4 molecules and TCR with specific 
mAbs was paralleled by an increase in the phosphotyrosine 
protein content of such activated T cells. Immunoblots with 
a phosphotyrosine-specific mAb (Fig. 9) showed overlapping 
patterns of tyrosine phosphorylated  substrates when com- 
paring BICD4.3 (Fig. 9 A) and BITCD4.20 (Fig. 9 B) stimu- 
lated with an anti-TCR;  an increase in tyrosine phosphory- 
lation of four cellular substrates (160, 97, 70, and 42 kd) was 
noted with a peak occurring at five rain after the cross-linking 
of TCR molecules.  An identical pattern of tyrosine phos- 
phorylation  was obtained when TCR and CD4 molecules 
were co-cross-linked  in BITCD4.20 (Fig. 9 D). In contrast, 
as already described (27),  tyrosine phosphorylation  of cel- 
lular substrates in cells expressing the wt CD4 molecule was 
significantly increased after the coaggregation  of wt CD4 
and TCR molecules.  This increase was detected as soon as 
30 s with a peak occurring at 1 rain. Phosphorylation  of a 
new substrate at 66 kD was noted under these conditions. 
These results suggest that this increase in tyrosine phosphory- 
lation content is not associated with the enhancement of IL-2 
production  observed after the coaggregation  of CD4 and 
TCR molecules. Conversely high levels of IL-2 production 
do not require these qualitative and quantitative modifica- 
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CD4-p56~-mediated increase in tyrosine phosphorylation. (A and B). 0.5 
x  106 cells (BICD4.3 and BITCD4.20) were incubated with F23.1 (0.75 
#g/ml) on ice for 1 h. cells were washed twice in PBS and TCR were 
cross-linked with GAM (5 #g/m1) at 37"C for 0, 0.5, 1, 5, 15, and 30 
min. Cells were then directly  lysed  in sample buffer and lysates  were run 
on SDS-PAGE. Immunoblots  were performed  by incubating with an an- 
tiphosphotyrosine mAb (1:800) and revealed with a mI-GAM. (C and 
/9) 0.5 x  106 ceUs  (BICD4.3 and BITCD4.20) were incubated with 0.75 
#g/ml F23.1 and 10 #g/ml L68 and samples were processed as in A. 
tions in tyrosine phosphorylation  of cellular substrates. Our 
results suggest that the activation of the tyrosine kinase ac- 
tivity of p56  ~k occurring  after the cross-linking  of CD4 is 
not  required  for this  enhancement. 
Discussion 
The BI and KK3 hybridomas are both dependent on the 
expression of CD4 for an optimal response to antigen. Tram- 
fection into  these calls  of CD4 mutants,  which do not as- 
sociate with  the  tyrosine  kinase  p5C  k,  has  enabled  us  to 
demonstrate  that  this interaction  is not required  for CD4- 
dependent enhancement of Ag-specific T ceU activation. The 
use of the human  CD4 molecule was justified since it can 
fully replace its routine counterpart (10),  even during T  cell 
differentiation (11). The response of the BI hybridoma to low 
concentrations  of Ag (beef insulin)  was fully restored after 
expression of the TCD4 mutant as well as the wt CD4 mol- 
ecule (Fig. 3 A, BI CD4.3, BI TCD4.20). Moreover stimula- 
tion by pork insulin,  which is entirely dependent on CD4 
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expression,  was as efficient in TCD4 as in wt CD4-expressing 
cells. This enhanced response in TCD4-expressing cells was 
not due to a donal variation, since several independently de- 
rived populations exhibited a similar pattern of response to 
both antigens.  Furthermore the lack of requirement for the 
CD4:p56 ~k association could not be attributed to aberrantly 
high  levels  of expression of TCD4  or TCR on these cells 
(Figs.  1 and 3 C).  Reexpression of the murine  CD4 mole- 
cule cannot explain these results since cell surface expression 
(Fig.  1) could not be detected. Moreover the Ag-specific re- 
sponses were not inhibited by routine CD4-specific mAbs 
(Figs.  5, 6,  and 7).  As expected,  the tyrosine phosphoryla- 
tion pathway is activated after TCR cross-linking  and this 
pathway is enhanced after the coaggregation ofwt CD4 and 
TCR molecules (Fig. 9 and reference 27). These results sug- 
gest that wt CD4:p56 ~k association is functional in our hy- 
bridoma. 
Our  results  contrast  with  those previously reported  by 
Miceli et al.  (28), who showed that  the response of the BI 
hybridoma to low concentrations of beef insulin was depen- 
dent on the association of CD4 with p56  ~k. This hybridoma 
expresses at least two different TCR ot chains (29), since the 
fusion partner  of beef insulin-specific T  cell blasts has  two 
productive rearrangements of the TCR ot chain. Qualitative 
and  quantitative  differences in  TCR  expression  caused by 
different TCR ot/B combinations could account for the differ- 
ences observed between the two laboratories.  Hence, levels 
of TCR complex specific for pork or beef insulin are likely 
to be overestimated when  these cells are stained or stimu- 
lated by a TCR mAb (F23.1) that recognizes the VB chain 
of the specific TCR.  This point is best illustrated with the 
BITCD4.25 population (Figs. 2 A and 3, A and B) and other 
wt CD4 populations (data not shown). BITCD4.25 responded 
very efficiently to low concentrations of F23.1 (Fig. 2 A) but 
very poorly to Ag (Fig.  3, A  and B). This point is further 
illustrated with KR3, the H-Y-specific MHC class II-restricted 
hybridoma that expresses only one TCK c~/13 combination 
on its surface. There was always a perfect correlation between 
the responses to Ag, Mls-1 ~ SAG, and TCR mAb stimula- 
tions (Figs.  2 and 4), further confirming that these cells had 
the same intrinsic capacity to produce IL-2 upon triggering 
through their TCR. As in the BI system, we could not show 
a difference in the response to TCD4, C420, and wt CD4-ex- 
pressing cells to H-Y stimulation in a quantitative assay de- 
pendent on the concentration of male splenocytes (Fig. 4 A). 
These results demonstrate  that  the critical role of CD4  in 
these assays is restricted  to its extracellular domains (tram- 
membrane  included). 
The requirement for the association of CD4 and CD8 with 
p56  ~k  in  Ag-specific  responses  is  largely  debated.  Three 
groups have clearly demonstrated that T cell hybridomas ex- 
pressing mutated forms of CD4 or CD8 that do not associate 
with  p56  u~  will  respond  less  efficiently  to  Ag  or  SAGs 
(30-32).  In contrast the above-mentioned results and other 
reports in the literature (33, 34) show that the CD4 or CD8 
extracellular  domain is sufficient to enhance Ag-specific T 
ceLl activation. 
As already mentioned, the use of hybridomas derived from 
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eral TCR combinations, provides a possible explanation for 
these discrepancies. However,  other explanations  must be 
evoked to explain differences between our results and those 
obtained by Glaichenhans et al. (30) who used T cell hybrid- 
omas expressing only one combination of TCK at//~ chains 
and observed a requirement for the CD4:p56 ~  association 
for optimal response to Ag and SAGs. The affinity of the 
TCR for its specific Ag could account for the requirement 
of the CD4:p56 k~ interaction or lack thereof in T  cell hy- 
bridomas.  In this context, it is important to note that both 
83/141 (35) and KR3 (Fig. 2) hybridomas are CD4 indepen- 
dent for their response to SAGs, compatible with the notion 
that this response is a high affinity interaction. However  both 
hybridomas require CD4 for their response to specific Ag. 
Moreover the 83/141 variant that was derived from L3T4 + 
cells obtained after immunization with beef insulin,  is less 
dependent on CD4 for its response to beef insulin than the 
variant pork insulin peptide, confirming that the affnity of 
the TCK for its specific  Ag dictates the requirement for CD4 
or CD8.  Whereas it appears that the affinity of TCR for 
pork insulin is very low, we cannot exclude that a TCR with 
an even weaker affinity for its Ag needs in its vicinity, the 
presence of p56 ~k associated with CD4. 
Variations  in  the  intrinsic  levels of p56 ~k  among  the 
different hybridomas  could also explain the differential re- 
quirement for the CD4:p56 ~  association, p56  t'~ expression 
has been shown to be required for T cell stimulation through 
the TCR (36). Furthermore, this molecule can exert its role 
in enhancing T cell activation even without being associated 
with CD4 (27). It is conceivable in this case that a minimal 
level of the p56 ~  molecule is required for TCK-mediated 
stimulation.  Coaggregation of CD4 with TCR by MHC 
class II molecules or by mAbs would yield the required local 
concentration of p56 ~  in the vicinity of the TCR in cells 
expressing low levels of the tyrosine kinase. 
CD4-dependent, Ag-specific stimulation is inhibited by 
CD4-specific mAbs.  Three nonexclusive mechanisms have 
been proposed: (a) perturbation of the interactions of CD4 
with its external ligands  (MHC and/or TCK) (7); (b) se- 
questration  of p56 uk from the TCR complex (16); and (c) 
transduction of a negative signal through the activation of 
p56  ~k (14). Availability of mutant forms of CD4 that are 
not associated to p56 ~ has allowed us to show that the latter 
two mechanisms do not play a major role in this inhibition. 
Sequestration of p56  ~k (when CD4 does not cocluster with 
the TCR)  or negative  signaling  (when p56  ~k is  activated 
by CD4 cross-linking)  could play a role in the inhibition 
observed  with cells expressing  wt  CD4.  However,  these 
mechanisms cannot be put forward for cells expressing CD4 
molecules that are not associated  with this kinase. Our results 
dearly show that CD4-specific mAbs are capable of abrogat- 
ing the CD4-dependent responses to beef insulin  (Fig. 5) 
and to H-Y (Fig. 6) by T cell hybridomas transfected with 
truncated or mutated forms of CD4 that are not associated 
with p5C  k. This inhibition is as efficient with all the mu- 
tants  of CD4  that  have been tested,  suggesting that  the 
mechanism involved in this phenomenon requires solely the 
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external domain of CD4. Since these cells most likely require 
a CD4-MHC class II interaction for an optimal response 
to Ag, it becomes difficult to determine if these mAbs affect 
the T  cell response by disrupting a CD4-dass  II or a CD4 
-TCK interaction. 
The use  of Mls-1  ~ stimulation,  which is  independent 
of the expression of CD4, has enabled us to address the role 
of CD4 interactions with ligands other than MHC class II 
in the inhibition by CD4-spedfic mAbs. As previously shown 
for CD4 dependent systems, we have been able to demon- 
strate that CD4-specific mAbs inhibit the activation by Mls-1  ~ 
of T cells expressing either wt CD4 or mutated CD4 (Fig. 
7) in a dose-dependent fashion. These observations further 
indicate  that  sequestration  or negative  signaling  through 
p56  ~  or inhibition of the CD4-MHC class II interaction 
are not the only mechanisms involved in the inhibition of 
T  cell activation by CD4-specific mAbs. 
The fact that the synergistic function of CD4 in T  cell 
activation occurs even when TCD4 or C420 CD4 are cross- 
linked with the TCK (Fig. 8) confirms the above statements. 
Hence, it is possible that the interaction of CD4 with the 
TCK modifies the conformation of the TCK complex, thereby 
increasing the affinity of the TCR for its ligand.  This ex- 
tracellular  association would occur equally well with the 
different mutants. Indeed it was shown that specific sets of 
TCR mAbs can induce an association with CD4 that results 
in changes in TCK conformation (17). Alternatively,  it is 
possible that CD4 is associated with other molecule(s) in- 
volved in T cell stimulation such as CD45 (18), which would 
be recruited equally well to the complex by wt or mutated 
forms of CD4. Aggregation of these molecules with the TCR 
complex could be sufficient to enhance T cell activation. On 
the other hand, disruption of these interactions  by CD4-specific 
mAbs could explain the inhibition observed with CD4 mAbs 
in CD4-independent stimulation. 
p56  ~i involvement in T cell activation  (36) and matura- 
tion has been clearly demonstrated (37). The experiments 
described here show that in these T cell hybridomas p56 ~k 
associated to CD4 is not required for CD4 to enhance Ag- 
specific responses. However this does not exclude the involve- 
ment of non-CD4-associated p56  kk in T cell stimulation. In- 
deed,  thymocytes in mice lacking  p56/a' are arrested  at  a 
stage of  differentiation which precedes the expression of CD4 
and CD8 (38), further confirming the role of p56 ~k, which 
is not associated with CD4.  Our results demonstrate that 
the enhancement by CD4 of Ag-specific responses is not due 
to the enzymatic activity of the CD4-associated Ick (28, 38). 
Rather,  it is dependent on the interaction of CD4 with its 
externals ligand. Other mechanisms similar to those proposed 
by Xu and Littman (39) and Killeen and Littman (38) could 
also be responsible for this enhancement. In addition to in- 
creasing adhesion between APCs and T cells by binding to 
MHC dass II molecules, CD4 can augment the affnity of 
the TCK for its ligand by stabilizing the conformation of 
the TCR when these two molecules are in close  contact. Struc- 
ture-function analysis of CD4 interaction with other ligands 
are currently being carried out to further delineate the im- 
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